RameshAShivdasaniMD

Professor, Medicine - Dana-Farber Cancer Institute, Harvard Medical School

Dr. Shivdasani is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
44 Binney St
Dana 720
Boston, MA 02115
Phone+1 617-632-5746

Fax+1 617-582-8490

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1989 - 1994
University of Michigan Medical SchoolClass of 1989

PubMed

492 citations
Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab
Kimio Yonesaka, Kreshnik Zejnullahu, Isamu Okamoto, Taroh Satoh, Federico Cappuzzo
Science Translational Medicine. 2011-09-07
1339 citations
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
Aleksandar Kostic, Dirk Gevers, Chandra Sekhar Pedamallu, Monia Michaud, Fujiko Duke
Genome Research. 2012-02-01
503 citations
The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer.
Mark Pomerantz, Nasim Ahmadiyeh, Li Jia, Paula Herman, Michael P. Verzi
Nature Genetics. 2009-06-28

Extensive Recovery of Embryonic Enhancer and Gene Memory Stored in Hypomethylated Enhancer DNAMarch 21st, 2020
Dana-Farber Scientists Solve Long-Debated Puzzle of How Intestine Heals ItselfFebruary 21st, 2020
Scientists Solve Long-Debated Puzzle of How the Intestine Heals ItselfFebruary 21st, 2020
Join now to see all